William A. Malkes

NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN.

NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN.

NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN.

NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN.